Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hemophilia Center of Western New York (HCWNY) is a specialized non-profit healthcare organization and federally designated Hemophilia Treatment Center (HTC) serving the Western New York region. Established in 1970, the center provides comprehensive, multidisciplinary care for individuals with hemophilia, von Willebrand disease, and other rare bleeding and clotting disorders. Their integrated care model includes hematology, nursing, social work, physical therapy, and a specialized 340B pharmacy program that helps fund patient services. HCWNY also actively participates in clinical research and national surveillance programs to advance the treatment of bleeding disorders. The center is dedicated to improving patient quality of life through education, advocacy, and personalized clinical management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemophilia Center of Western New York.